Požymis
Excessive sweating
Klinikinis pavadinimas: Hyperhidrosis
Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.
Santrauka
- Taip pat vadinama
- Increased sweating, Profuse sweating, Sweating, Sweating profusely, Sweating, increased, Diaphoresis
- Kūno sistema
- Abnormality of the integument
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Excessive sweating, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test137 genų susiję su Excessive sweating
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Excessive sweating. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| BOLA3bolA family member 3 | Visada | 1 ligoje |
| DSG1desmoglein 1 | Visada | 1 ligoje |
| IRF4interferon regulatory factor 4 | Visada | 1 ligoje |
| LIFRLIF receptor subunit alpha | Visada | 2 ligose |
| MAP2K1mitogen-activated protein kinase kinase 1 | Visada | 2 ligose |
| MAP2K2mitogen-activated protein kinase kinase 2 | Visada | 2 ligose |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Visada | 1 ligoje |
| SLC18A2solute carrier family 18 member A2 | Visada | 2 ligose |
| SUCLG1succinate-CoA ligase GDP/ADP-forming subunit alpha | Visada | 2 ligose |
| AIPAHR interacting HSP90 co-chaperone | Labai dažnai (80–99%) | 2 ligose |
| AQP5aquaporin 5 | Labai dažnai (80–99%) | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Labai dažnai (80–99%) | 1 ligoje |
| BIRC3baculoviral IAP repeat containing 3 | Labai dažnai (80–99%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Labai dažnai (80–99%) | 2 ligose |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Labai dažnai (80–99%) | 1 ligoje |
| CLCF1cardiotrophin like cytokine factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| CRLF1cytokine receptor like factor 1 | Labai dažnai (80–99%) | 2 ligose |
| ELP1elongator acetyltransferase complex subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| FOXP1forkhead box P1 | Labai dažnai (80–99%) | 1 ligoje |
| FUCA1alpha-L-fucosidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Labai dažnai (80–99%) | 1 ligoje |
| GPR101G protein-coupled receptor 101 | Labai dažnai (80–99%) | 2 ligose |
| HNF4Ahepatocyte nuclear factor 4 alpha | Labai dažnai (80–99%) | 1 ligoje |
| HPGD15-hydroxyprostaglandin dehydrogenase | Labai dažnai (80–99%) | 3 ligose |
| IGHimmunoglobulin heavy locus | Labai dažnai (80–99%) | 1 ligoje |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Labai dažnai (80–99%) | 1 ligoje |
| KIF1Akinesin family member 1A | Labai dažnai (80–99%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Labai dažnai (80–99%) | 1 ligoje |
| MALT1MALT1 paracaspase | Labai dažnai (80–99%) | 1 ligoje |
| MEN1menin 1 | Labai dažnai (80–99%) | 2 ligose |
| NLRP3NLR family pyrin domain containing 3 | Labai dažnai (80–99%) | 1 ligoje |
| PHOX2Bpaired like homeobox 2B | Labai dažnai (80–99%) | 2 ligose |
| RETREG1reticulophagy regulator 1 | Labai dažnai (80–99%) | 1 ligoje |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Labai dažnai (80–99%) | 2 ligose |
| SERPINB7serpin family B member 7 | Labai dažnai (80–99%) | 1 ligoje |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Labai dažnai (80–99%) | 3 ligose |
| WNK1WNK lysine deficient protein kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| YY1YY1 transcription factor | Labai dažnai (80–99%) | 1 ligoje |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Dažnai (30–79%) | 1 ligoje |
| CDH23cadherin related 23 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 97 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CDKN2Acyclin dependent kinase inhibitor 2A | Dažnai (30–79%) | 1 ligoje |
| CLCN6Cl-/H+ antiporter 6 | Dažnai (30–79%) | 1 ligoje |
| CTC1CST telomere replication complex component 1 | Dažnai (30–79%) | 1 ligoje |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 1 ligoje |
| CTSHcathepsin H | Dažnai (30–79%) | 1 ligoje |
| DDCdopa decarboxylase | Dažnai (30–79%) | 2 ligose |
| DKC1dyskerin pseudouridine synthase 1 | Dažnai (30–79%) | 2 ligose |
| DSTdystonin | Dažnai (30–79%) | 1 ligoje |
| FGFR2fibroblast growth factor receptor 2 | Dažnai (30–79%) | 2 ligose |
| FLRT1fibronectin leucine rich transmembrane protein 1 | Dažnai (30–79%) | 1 ligoje |
| GNA14G protein subunit alpha 14 | Dažnai (30–79%) | 2 ligose |
| HCRThypocretin neuropeptide precursor | Dažnai (30–79%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Dažnai (30–79%) | 2 ligose |
| JAK2Janus kinase 2 | Dažnai (30–79%) | 1 ligoje |
| JUPjunction plakoglobin | Dažnai (30–79%) | 1 ligoje |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Dažnai (30–79%) | 1 ligoje |
| KLC2kinesin light chain 2 | Dažnai (30–79%) | 2 ligose |
| MOGmyelin oligodendrocyte glycoprotein | Dažnai (30–79%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Dažnai (30–79%) | 1 ligoje |
| NGLY1N-glycanase 1 | Dažnai (30–79%) | 1 ligoje |
| NHP2NHP2 ribonucleoprotein | Dažnai (30–79%) | 1 ligoje |
| NOP10NOP10 ribonucleoprotein | Dažnai (30–79%) | 1 ligoje |
| NPM1nucleophosmin 1 | Dažnai (30–79%) | 1 ligoje |
| P2RY11purinergic receptor P2Y11 | Dažnai (30–79%) | 1 ligoje |
| PARNpoly(A)-specific ribonuclease | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Dažnai (30–79%) | 2 ligose |
| RTEL1regulator of telomere elongation helicase 1 | Dažnai (30–79%) | 1 ligoje |
| SLC16A2solute carrier family 16 member 2 | Dažnai (30–79%) | 1 ligoje |
| SLURP1secreted LY6/PLAUR domain containing 1 | Dažnai (30–79%) | 2 ligose |
| SPRsepiapterin reductase | Dažnai (30–79%) | 1 ligoje |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Dažnai (30–79%) | 1 ligoje |
| TATtyrosine aminotransferase | Dažnai (30–79%) | 1 ligoje |
| TERCtelomerase RNA component | Dažnai (30–79%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 2 ligose |
| THPOthrombopoietin | Dažnai (30–79%) | 1 ligoje |
| TINF2TERF1 interacting nuclear factor 2 | Dažnai (30–79%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Dažnai (30–79%) | 1 ligoje |
| TYMSthymidylate synthetase | Dažnai (30–79%) | 1 ligoje |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Dažnai (30–79%) | 1 ligoje |
| WRAP53WD repeat containing antisense to TP53 | Dažnai (30–79%) | 1 ligoje |
| ZNF365zinc finger protein 365 | Dažnai (30–79%) | 1 ligoje |
| ZNRF3zinc and ring finger 3 | Dažnai (30–79%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Kartais (5–29%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Kartais (5–29%) | 1 ligoje |
| COL17A1collagen type XVII alpha 1 chain | Kartais (5–29%) | 1 ligoje |
| CTSBcathepsin B | Kartais (5–29%) | 1 ligoje |
| CUL4Bcullin 4B | Kartais (5–29%) | 1 ligoje |
| FBXO11F-box protein 11 | Kartais (5–29%) | 1 ligoje |
| GRB10growth factor receptor bound protein 10 | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Kartais (5–29%) | 2 ligose |
| KRT1keratin 1 | Kartais (5–29%) | 1 ligoje |
| KRT14keratin 14 | Kartais (5–29%) | 1 ligoje |
| KRT16keratin 16 | Kartais (5–29%) | 1 ligoje |
| KRT5keratin 5 | Kartais (5–29%) | 1 ligoje |
| KRT9keratin 9 | Kartais (5–29%) | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PLAAphospholipase A2 activating protein | Kartais (5–29%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Kartais (5–29%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Kartais (5–29%) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Kartais (5–29%) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Kartais (5–29%) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Kartais (5–29%) | 1 ligoje |
| SLC39A14solute carrier family 39 member 14 | Kartais (5–29%) | 1 ligoje |
| SPRED2sprouty related EVH1 domain containing 2 | Kartais (5–29%) | 1 ligoje |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Kartais (5–29%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 2 ligose |
| WNT10AWnt family member 10A | Kartais (5–29%) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Retai (1–4 %) | 1 ligoje |
| GLAgalactosidase alpha | Retai (1–4 %) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Retai (1–4 %) | 1 ligoje |
| HINT1histidine triad nucleotide binding protein 1 | Retai (1–4 %) | 2 ligose |
| HMBShydroxymethylbilane synthase | Retai (1–4 %) | 1 ligoje |
| HRASHRas proto-oncogene, GTPase | Retai (1–4 %) | 1 ligoje |
| IGF2insulin like growth factor 2 | Retai (1–4 %) | 1 ligoje |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Retai (1–4 %) | 1 ligoje |
| SLC12A3solute carrier family 12 member 3 | Retai (1–4 %) | 1 ligoje |
| COL6A1collagen type VI alpha 1 chain | Neužfiksuota | 1 ligoje |
| HEXBhexosaminidase subunit beta | Neužfiksuota | 1 ligoje |
| IGHMBP2immunoglobulin mu DNA binding protein 2 | Neužfiksuota | 1 ligoje |
| KIF1Bkinesin family member 1B | Neužfiksuota | 1 ligoje |
| KRT6Akeratin 6A | Neužfiksuota | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Neužfiksuota | 1 ligoje |
| RETret proto-oncogene | Neužfiksuota | 1 ligoje |
| SCN11Asodium voltage-gated channel alpha subunit 11 | Neužfiksuota | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Neužfiksuota | 1 ligoje |
| SDHCsuccinate dehydrogenase complex subunit C | Neužfiksuota | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Neužfiksuota | 1 ligoje |
| TMEM127transmembrane protein 127 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites